PUBLISHER: Grand View Research | PRODUCT CODE: 2067533
PUBLISHER: Grand View Research | PRODUCT CODE: 2067533
The global surgical robots market size was estimated at USD 6.64 billion in 2025 and is projected to reach USD 18.49 billion by 2033, growing at a CAGR of 13.5% from 2026 to 2033. Technological advancements, increased investments from regional and international stakeholders, and the rising prevalence of chronic diseases, particularly in knee and hip replacement surgeries, are key market growth drivers.
In March 2025, according to the American College of Rheumatology, over 790,000 knee and 544,000 hip replacements were performed annually in the U.S., reflecting a steady increase as the population ages. The growing investments from regional and international stakeholders in the development of advanced medical products are contributing positively to market expansion. Enhancements in visualization and navigation, particularly through surgical navigation systems, are essential for the technological advancement of robotic surgical procedures. High-definition 3D cameras and augmented reality overlays provide surgeons with an immersive perspective of the operative area, improving their spatial awareness and decision-making skills. For instance, in February 2024, CMR Surgical launched its latest innovation, the vLimeLite. This integrated fluorescence imaging system is designed to enhance procedures by providing surgeons with improved visualization capabilities using Indocyanine Green (ICG). ICG is a fluorescent dye that is commonly used in medical imaging to visualize blood flow and tissue perfusion.
In May 2023, the American College of Surgeons reported that over 12 million surgeries had been performed using da Vinci systems globally. There is a 22% increase in clinical procedures utilizing these systems from 2022 to 2023, signifying a growing trend towards adopting advanced technologies. This surge in demand reflects the effectiveness of robotic systems and a shift in practices towards minimally invasive techniques that improve patient outcomes and reduce recovery times.
The increasing prevalence of bone degenerative diseases, such as arthritis and osteoporosis, is driving a surge in hip and knee replacement surgeries, significantly impacting market growth. Osteoporosis impacts around 10 million individuals in the U.S., and approximately 75 million people across the U.S., Europe, and Japan collectively. Projections suggest that by 2040, 1 in 4 U.S. adults (78.4 million) will have doctor-diagnosed arthritis, and 1 in 9 adults (34.6 million) will experience arthritis-attributable activity limitations. As the demand for joint replacement procedures rises, advancements in robotic-assisted surgery are transforming the orthopedic landscape by improving precision, reducing recovery times, and enhancing patient outcomes.
The increasing demand for advanced medical technologies is reshaping the healthcare landscape. In particular, the operational sector is adopting innovative solutions to enhance patient outcomes and streamline procedures. With ongoing advancements, healthcare providers are better equipped to address complex medical challenges and improve overall efficiency. For instance, a report from the World Health Organization in February 2024 highlighted that there were over 20 million new cancer cases worldwide, with 53.5 million individuals surviving at least five years of post-diagnosis.
Global Surgical Robotics Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels, and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global surgical robots market report based on component, application, end-use, and region: